GENE ONLINE|News &
Opinion
Blog

2019-11-05| China

2019 CSCO China, with highlights on proteomics-driven precision medicine, oncology treatment and quality control, and breakthroughs in drug developments

by GeneOnline
Share To
The 22nd annual installment of the Chinese Society of Clinical Oncology (CSCO) meeting, took place at the Xiamen International Conference Center on September 19, for 4 days. The theme of the 22nd conference was “Precision & Intelligence: Hope to conquer cancer”. The conference had four aims: (1) Encourage the exchange of new knowledge and technology in clinical oncology; (2) Promote scientific exchange between China and other countries; (3) Support academic research; (4) Support innovation in the industry. The conference attracted approximately 30,000 participants, more than 600 speakers and paper presenters from China and abroad, and 275 manufacturers from China. Geneonline attended the CSCO meeting, and reported the highlights of this conference.

GO Prime with only $1.49 now

LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top